923
Views
1
CrossRef citations to date
0
Altmetric
Research Papers

The immunogenicity of the intradermal injection of seasonal trivalent influenza vaccine containing influenza A(H1N1)pdm09 in COPD patients soon after a pandemic

, , , , , , & show all
Pages 1728-1737 | Received 28 Oct 2015, Accepted 28 Jan 2016, Published online: 06 May 2016

References

  • Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-55; PMID:17507545; http://dx.doi.org/10.1164/rccm.200703-456SO
  • Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125:2011-20; PMID:15189916; http://dx.doi.org/10.1378/chest.125.6.2011
  • Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, Maranetra KN. The immunogenicity of intradermal influenza vaccination in COPD patients. Vaccine 2010; 28:4045-51; PMID:20412877; http://dx.doi.org/10.1016/j.vaccine.2010.04.006
  • Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines (CPMP/BWP/214/96). Euro Agency Eval Med Products 12 March 1997. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf (accessed March 8, 2010).
  • Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, Demanet E, Heijmans S, Van Belle P, Weber F, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009; 7:13; PMID:19341446; http://dx.doi.org/10.1186/1741-7015-7-13
  • Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, Leroux-Roels G. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 2008; 26:6614-9; PMID:18930093; http://dx.doi.org/10.1016/j.vaccine.2008.09.078
  • Chi RC, Rock MT, Neuzil KM. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010; 50:1331-8; PMID:20377407; http://dx.doi.org/10.1086/652144
  • Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009; 27:7304-12; PMID:19849996; http://dx.doi.org/10.1016/j.vaccine.2009.10.033
  • World Health Organization. World now at the start of 2009 influenza pandemic. Available from: http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/ (accessed March 8, 2010).
  • World Health Organization. H1N1 in post-pandemic period. Available at http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/ (accessed August 20, 2010).
  • Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007; 25:659-63; PMID:17011678; http://dx.doi.org/10.1016/j.vaccine.2006.08.026
  • Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004; 351:2286-94; PMID:15525713; http://dx.doi.org/10.1056/NEJMoa043555
  • Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007; 25:6755-63; PMID:17692438; http://dx.doi.org/10.1016/j.vaccine.2007.06.066
  • Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295-301; PMID:15525714; http://dx.doi.org/10.1056/NEJMoa043540
  • Committee for Proprietary Medicinal Products (CPMP). Guideline on influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context (EMEA/CHMP/VWP/263499/2006). Euro Agency Eval Med Prod 24 January 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003872.pdf (accessed July 17, 2014).
  • Hung IF, Levin Y, To KK, Chan KH, Zhang AJ, Li P, Li C, Xu T, Wong TY, Yuen KY. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine 2012; 30:6427-35; PMID:22910287; http://dx.doi.org/10.1016/j.vaccine.2012.08.014
  • Prachayangprecha S, Makkoch J, Payungporn S, Chieochansin T, Vuthitanachot C, Vuthitanachot V, Theamboonlers A, Poovorawan Y. Serological analysis of human pandemic influenza (H1N1) in Thailand. J Health Popul Nutr 2010; 28:537-44; PMID:21261198; http://dx.doi.org/10.3329/jhpn.v28i6.6601
  • Gorse GJ, Falsey AR, Fling JA, Poling TL, Strout CB, Tsang PH. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age. Vaccine 2013; 31:2358-65; PMID:23499604; http://dx.doi.org/10.1016/j.vaccine.2013.03.008
  • Kiertiburanakul S, Malathum K, Watcharananan SP, Bunupuradah P, Piebpien P, Rujiraviroj U, Likitsinsipon W, Apivanich S, Kehachindawat P, Burakitcharoen R, et al. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand. Am J Infect Control 2011; 39:525-8; PMID:21612842; http://dx.doi.org/10.1016/j.ajic.2010.09.011
  • Flynn PM, Shenep JL, Mao L, Crawford R, Williams BF, Williams BG. Influence of needle gauge in Mantoux skin testing. Chest 1994; 106:1463-5; PMID:7956403; http://dx.doi.org/10.1378/chest.106.5.1463
  • Arnou R, Frank M, Hagel T, Prebet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011; 28:555-65; PMID:21626269; http://dx.doi.org/10.1007/s12325-011-0035-z
  • Kositanont U, Kanyok R, Wasi C, Wongsurakiat P, Suthamsmai T, Maranetra N. Occurrence and protective level of influenza infections using serology in patients with COPD in vaccination study. J Med Assoc Thai 2004; 87:964-9; PMID:15471303
  • PrachayangprechaS, MakkochJ, SuwannakarnK, VichaiwattanaP, KorkongS, TheamboonlersA, PoovorawanY. Epidemiology of seasonal influenza in Bangkok between 2009 and 2012. J Infect Dev Ctries 2013; 7:734-40.
  • Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R. Kinetics of the antibody response to seasonal influenza vaccination among the elderly. Viral Immunol 2012; 25:471-6; PMID:23061793; http://dx.doi.org/10.1089/vim.2012.0024
  • Kositanont U, Wongsurakiat P, Pooruk P, Maranetra N, Puthavathana P. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients. Viral Immunol 2010; 23:329-34; PMID:20565296; http://dx.doi.org/10.1089/vim.2009.0082
  • Praditsuwan R, Assantachai P, Wasi C, Puthavatana P, Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 2005; 88:256-64; PMID:15962680
  • Eadie MB, Stott EJ, Grist NR. Virological studies in chronic bronchitis. Br Med J 1966; 2:671-3; PMID:20791109; http://dx.doi.org/10.1136/bmj.2.5515.671
  • Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:1S-23S; PMID:16428686; http://dx.doi.org/10.1378/chest.129.1.1
  • Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-204; PMID:3492164; http://dx.doi.org/10.7326/0003-4819-106-2-196
  • Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-63; PMID:14726171; http://dx.doi.org/10.1016/S0140-6736(03)15268-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.